Comment on: Efficacy and safety of biologics targeting interleukin-6, -12/23 and -17 pathways for peripheral psoriatic arthritis: a network meta-analysis
Rheumatology (Oxford)
.
2018 Nov 1;57(11):2061-2062.
doi: 10.1093/rheumatology/key253.
Authors
Chenyang Lu
1
,
Yi Liu
1
Affiliation
1
Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.
PMID:
30239893
DOI:
10.1093/rheumatology/key253
No abstract available
Publication types
Comment
MeSH terms
Arthritis, Psoriatic*
Biological Factors
Biological Products*
Humans
Interleukin-6
Network Meta-Analysis
Substances
Biological Factors
Biological Products
Interleukin-6